YAOPU (Shanghai) Pharmaceutical Technology Co., LTD. (YAOPU), founded in 2017, is a national high-tech enterprise focusing on small molecule APIs and related industries. The company provides small molecule API process development & manufacturing services (CDMO) and innovative chemical products such as small nucleic acid drug(ASO\iRNA) raw materials, single molecular wight PEG derivatives and specialty building blocks. Since its establishment, Yaopu has provided one-stop commissioned research and development and customized production services for big pharma companies and new drug biotech companies at home and abroad, covering the research and development and production of API process from pre-clinical, clinical to commercialization of drugs, as well as the customized production of starting materials and key intermediates under regulations. The company has an efficient and professional team in the development, production, management, registration and application of API process, with an international vision and many years of project operation experience in the pharmaceutical industry, enjoying dozens of new drug and generic drug projects at home and abroad (including FDA/EMA/NMPA, etc.) successful application experience. At present, the company has 4200 square meters of advanced facilities in Shanghai R & D center, in Zhejiang, Anhui and Shandong GMP and non-GMP production bases, the company has always been unremitting to strengthen the construction of technology innovation system, adhering to the advanced project management, quality management and EHS management philosophy, From process development, registration and application to commercial production to provide customers and partners with professional, high quality, in line with the requirements of the regulations of products and services.